Severe Vaso-Occlusive and Ocular Decompression Retinopathy Revealing a Sickle Cell Trait in a Patient with Herpetic Uveitis.

Acetazolamide anhydrase carbonic inhibitor herpetic uveitis ocular decompression retinopathy retinal arterial occlusion sickle cell trait

Journal

Ocular immunology and inflammation
ISSN: 1744-5078
Titre abrégé: Ocul Immunol Inflamm
Pays: England
ID NLM: 9312169

Informations de publication

Date de publication:
28 Nov 2022
Historique:
entrez: 28 11 2022
pubmed: 29 11 2022
medline: 29 11 2022
Statut: aheadofprint

Résumé

To describe a patient with hypertensive herpetic uveitis complicated by arterial retinal occlusions and a decompression retinopathy revealing a sickle cell trait. Case report. A 24-year-old African man presented with a hypertensive herpetic keratouveitis. A brutal lowering of the intraocular pressure (IOP) by systemic acetazolamide resulted in a ocular decompression retinopathy and multiple arterial occlusions involving the macular and the mid-periphery retina. A hemoglobin electrophoresis revealed a sickle cell trait. Under rare circumstances, vaso occlusive events can occur in patients with a sickle cell trait. We identified high IOP and acetazolamide to be responsible of an increased blood viscosity and a reduction of the vessels' caliber, resulting in sickling and arterial retinal occlusions. We recommend a thorough anamnesis and a sickle cell screening for patients of African or Mediterranean descent with acute elevated IOP, especially if they have to be treated with carbonic anhydrase inhibitors.

Identifiants

pubmed: 36442016
doi: 10.1080/09273948.2022.2147545
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-4

Auteurs

Jonathan Toutain (J)

Departement Ophtalmologique, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

Selim Fares (S)

Departement Ophtalmologique, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.
Plateforme d'Investigation Clinique, Centre d'investigation clinique, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

Isabelle Cochereau (I)

Departement Ophtalmologique, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

Mohamed Ali Gargouri (MA)

Departement Ophtalmologique, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

Chérif Titah (C)

Departement Ophtalmologique, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

Classifications MeSH